Confirm delete?

Bertin Bioreagent
logo
All categories
Contact Us
You are here :

(±)-CP 47,497

  • Zoom
    (±)-<wbr/>CP 47,497
  • (±)-<wbr/>CP 47,497
Cat No: 10913
Biochemicals - Drugs Of Abuse
Cayman
Price is excluding VAT and does not include packaging neither shipping

CP 47,497 is a monophenol cannabimimetic compound that binds the central cannabinoid (CB1) receptor with a Ki value of 2.2 nM.{16403,6746} It is equivalent in analgesic potency to Δ9-THC and exhibits other CB biological activities as well.

More

This article is not for sale online.
Contact us for more information about this article.

Territorial Availability: Available through Bertin Pharma only in Europe
Special Advice: regulated item by French and American Administrations DEA + ANSM / special delivery time and additional fees.
Synonyms:
  • rel-5-(1,1-dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl]-phenol
Correlated keywords:
  • receptors agonist CB1 potent cannabinoid DELTA9-THC Δ9-THC CP47,497 CP-47,497 CP47497 CP-47497 CP 47,497 CP 47497 CP47,947 CP-47,947 CP-47947 CP47947 CP 47947 CP 47,947 (±)-CP 47497 (±)-CP-47497 (±)-CP-47,497 cannabinoids cbs synthetic 16851 analytical references standards
Product Overview:
CP 47,497 is a monophenol cannabimimetic compound that binds the central cannabinoid (CB1) receptor with a Ki value of 2.2 nM.{16403,6746} It is equivalent in analgesic potency to Δ9-THC and exhibits other CB biological activities as well.
Size 10 mg
Shipping dry ice
Stability Store at -20 degrees; shelf life 730 days
CAS Number 70434-82-1
Molecular Formula C21H34O2
SMILES O[C@H]1C[C@@H](C2=CC=C(C(C)(C)CCCCCC)C=C2O)CCC1
Molecular Weight 318,5
Formulation A crystalline solid
Purity ≥95%
Custom Code 2907.19
UNSPSC code 12352100

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.

/ We also advise you

Cross selling for this product : (±)-<wbr/>CP 47,497 There are 10 products.

Search